A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia

Francis J. Giles, Jorge E. Cortes, Hagop M. Kantarjian, Susan M. O'Brien, Elihu Estey, Miloslav Beran

Research output: Contribution to journal › Article › peer-review